Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1999
11/09/1999US5980882 A solid or a gel medicine comprising dextromethorphan, codeine, morphine, hydrcodone, pseudoephedrine, or phenylpropanolamine and complexed with chelating agent selected from edta or a salt of edta; storage stability
11/09/1999US5980827 Passing air containing airborne microorganisms through air path means and disinfecting air in said path means by passing air over demand disinfectant resin such that airborne microorganisms contact said resin and are devitalized thereby,
11/09/1999CA2159424C Use of alkyl n-(hydroxyalkyl)carbamates in a cosmetic composition
11/09/1999CA2119129C Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
11/09/1999CA2087976C Process for producing magnetically responsive polymer particles and application thereof
11/09/1999CA2003808C Crosslinked polyacrylic acid
11/04/1999WO1999056129A1 Methods of selecting internalizing antibodies
11/04/1999WO1999055774A1 Coprecipitation of cellulose esters with functional additives and compositions thus obtainable
11/04/1999WO1999055760A1 Non cross-linked block polyetherester, preparation and uses
11/04/1999WO1999055736A2 Derivatives of arabinogalactan and compositions including the same
11/04/1999WO1999055730A2 Polyepitope carrier protein
11/04/1999WO1999055720A1 Targeted gene delivery to cells by filamentous bacteriophage
11/04/1999WO1999055386A2 Stimulus sensitive gel with radioisotope and methods of making
11/04/1999WO1999055383A2 Improvements in or relating to diagnostic/therapeutic agents
11/04/1999WO1999055377A2 Polyol-ifn-beta conjugates
11/04/1999WO1999055376A1 Peg-lhrh analog conjugates
11/04/1999WO1999055375A1 Stable mitoxantron solutions
11/04/1999WO1999055374A1 Use of an adhesive composition over a bioactive polymerization initiator or accelerator
11/04/1999WO1999055373A1 Saccharide-containing compositions
11/04/1999WO1999055372A1 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine
11/04/1999WO1999055367A1 INTERNALIZING ErbB2 ANTIBODIES
11/04/1999WO1999055363A1 Compositions and methods for tolerization in immune complex-mediated disease progression
11/04/1999WO1999055353A2 Protein formulations
11/04/1999WO1999055348A2 Stabilised virus preparation
11/04/1999WO1999055345A1 Combination viral-based and gene-based therapy of tumors
11/04/1999WO1999055337A1 Stabile compositions comprising levosimendan and alginic acid
11/04/1999WO1999055332A1 Medicinal compositions
11/04/1999WO1999055328A1 Fire-resistant non-explosive solid mixtures containing nitroglycerine and water-free lactose
11/04/1999WO1999055327A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate
11/04/1999WO1999055320A1 Oral formulation comprising biguanide and an organic acid
11/04/1999WO1999055313A1 Pellets having a core coated with a lipid lowering agent and a polymer
11/04/1999WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
11/04/1999WO1999055310A1 Stabilized protein crystals, formulations containing them and methods of making them
11/04/1999WO1999055309A1 Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them
11/04/1999WO1999055308A1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin
11/04/1999WO1999055306A1 Pharmaceutical composition comprising factor viii and neutral liposomes
11/04/1999WO1999055305A2 Controlled release peroral compositions of levosimendan
11/04/1999WO1999055304A1 Methods and compositions for stabilizing acetylcholine compositions
11/04/1999WO1999055287A1 Topical anesthetic formulation
11/04/1999WO1999043355A3 Formulations containing oxaliplatin
11/04/1999WO1999042597A9 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/04/1999WO1999040921A3 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/04/1999WO1999037788A9 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/04/1999CA2565375A1 Polyol-ifn-beta conjugates
11/04/1999CA2367888A1 Herbal composition and medicament against diabetes mellitus type ii manufactured thereof
11/04/1999CA2330934A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate
11/04/1999CA2330498A1 Non cross-linked block polyetherester, preparation and uses
11/04/1999CA2330481A1 Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them
11/04/1999CA2330479A1 Use of an adhesive composition over a bioactive polymerization initiator or accelerator
11/04/1999CA2330476A1 Stabilized protein crystals, formulations containing them and methods of making them
11/04/1999CA2330451A1 Polyol-ifn-beta conjugates
11/04/1999CA2330448A1 Peg-lhrh analog conjugates
11/04/1999CA2330391A1 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine
11/04/1999CA2330318A1 Derivatives of arabinogalactan and compositions including the same
11/04/1999CA2329908A1 Targeted gene delivery to cells by filamentous bacteriophage
11/04/1999CA2329864A1 Fire-resistant non-explosive solid mixtures containing nitroglycerine and water-free lactose
11/04/1999CA2328970A1 Pellets having a core coated with a lipid lowering agent and a polymer
11/04/1999CA2327506A1 Combination viral-based and gene-based therapy of tumors
11/04/1999CA2326377A1 Internalizing erbb2 antibodies
11/04/1999CA2326376A1 Polyepitope carrier protein
11/03/1999EP0953639A1 FAPalpha-specific antibody with improved producibility
11/03/1999EP0953630A1 Transesterification products of corn oil and glycerol and their use in pharmaceutical compositions
11/03/1999EP0953362A2 Methods and apparatus for the delivery of solid drug compositions
11/03/1999EP0953359A1 Pharmaceutical composition for oral administration
11/03/1999EP0953358A1 Use of coplymers comprising N-Vinyllactam and/or N-Vinylamine as matrix for preparing solid pharmaceutical and/or application forms
11/03/1999EP0953357A1 Nephrotropic drugs
11/03/1999EP0953349A1 Compositions comprising nitroglycerin and anhydrous lactose
11/03/1999EP0953347A2 Use of graft polymers containing polyalkyleneoxides as solubilizers
11/03/1999EP0953153A1 Novel method of diagnosing and treating gliomas
11/03/1999EP0953053A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/03/1999EP0953009A1 A process for preparing polymeric microgels
11/03/1999EP0952867A2 Device for local administration of solid and semisolid formulations, sustained-release formulations for parenteral administration and method of preparation
11/03/1999EP0952855A1 Use of hyaluronan in gene therapy
11/03/1999EP0952853A2 Conjugate comprising an active agent, a polypeptide and a polyether
11/03/1999EP0952852A1 Stabilized hinokitiol and compositions containing same
11/03/1999EP0952843A2 Pharmaceutical formulations for sustained drug delivery
11/03/1999EP0952841A1 Site-specific biomolecular complexes
11/03/1999EP0952837A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents
11/03/1999EP0952829A1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same
11/03/1999EP0952824A1 Enteric coating, comprising alginic acid, for an oral preparation
11/03/1999EP0952823A1 Stabilized pharmaceutical compositions and process for the preparation thereof
11/03/1999EP0952822A1 Chitosan-gelatin a microparticles
11/03/1999EP0952821A1 Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
11/03/1999EP0952819A1 Biologically active composition
11/03/1999EP0952818A1 Stable anhydrous formulation
11/03/1999EP0952770A1 System for rendering substantially non-dissoluble bio-affecting agents bio-available
11/03/1999EP0859595B1 Therapeutic preparation for the transdermal administration of active substances
11/03/1999EP0754033B1 Heterofunctional, mucoadhesive dosage form
11/03/1999EP0744944B1 Sexual steroid-containing transdermal therapeutic systems
11/03/1999EP0655069B1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
11/03/1999EP0596984B1 Preparation of microparticles
11/03/1999CN1234063A Collagen or gelatin crumble composition and use
11/03/1999CN1233960A Chlorofluorocarbon-free mometasone furoate aerosol formulations
11/03/1999CN1233959A Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their prepn.
11/03/1999CN1233954A Taste-masked microcapsule compositions and method for mfg. same
11/03/1999CN1233586A Precipitated silica granules
11/03/1999CN1233468A Pharmaceutical composition comprising bisphosphonic acid
11/03/1999CN1046094C Use of holoside for preparing in-site gelate, ophthalmic composition
11/02/1999US5977330 As humectants for skin and mucous membranes; antideposit agents
11/02/1999US5977314 Catalytic antibodies against cocaine
1 ... 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 ... 1712